← All indications
Opioid-Related Disorders
Disorders related to or resulting from abuse or misuse of OPIOIDS.
Subtype terms (4)
More specific conditions that are subtypes of Opioid-Related Disorders in the MeSH hierarchy.
- Heroin Dependence
28 drugs (24 approved, 4 experimental)
- Morphine Dependence
3 drugs approved
- Opiate Overdose
11 drugs (9 approved, 2 experimental)
- Opium Dependence
Drugs by status
Approved for this indication (8)
Phase 4 trials (41)
- vitamin d3
- acetazolamide
- ketamine
- ibuprofen
- valproic acid
- gabapentin
- cabotegravir
- dolutegravir
- tenofovir
- lamivudine
- desogestrel
- acetaminophen
- nicotine
- lidocaine
- epinephrine
- rifapentine
- sofosbuvir
- sufentanil
- articaine
- desvenlafaxine
- bupivacaine
- radiolabeled albumin technetium Tc-99m albumin colloid kit
- emtricitabine
- clonidine
- hydromorphone
- velpatasvir
- dexmedetomidine
- pibrentasvir
- fentanyl
- isopropyl alcohol
- +11 more
Phase 3 trials (23)
Phase 2 trials (62)
- nitrous oxide
- mannitol
- hydrocodone
- oxytocin
- urea
- buspirone
- alprazolam
- cariprazine
- lamotrigine
- citalopram
- oxycodone
- cycloserine
- prednisone
- disulfiram
- duloxetine
- suvorexant
- dynorphin 1-13
- isoflurane
- sevoflurane
- liraglutide
- sodium oxybate
- hydrocortisone
- ibudilast
- levetiracetam
- levodopa
- carbidopa
- ketone
- lemborexant
- nalmefene
- naloxegol
- +32 more
Phase 1 trials (35)
- propofol
- methylprednisolone
- 6beta-naltrexol
- phno
- omar
- acetylcysteine
- Carfentanil
- cisatracurium
- esmolol
- nifedipine
- palmitoylethanolamide
- ziprasidone
- guanfacine
- nalbuphine
- succinylcholine
- risperidone
- rocuronium
- calcitriol
- verapamil
- lacosamide
- aripiprazole
- telaprevir
- rilpivirine
- aprepitant
- [18f]pi-2620
- nyx-783
- bi 1356225
- magnesium stearate
- asp8082
- cvl-354
- +5 more
Other trials (7)
Organizations
Organization Involved with Phase 4 Indications (77)
- Gilead Sciences
- AstraZeneca
- Merck
- Pfizer
- Alkermes
- Indivior Inc.
- Member Companies of the Opioid PMR Consortium
- Orexo AB
- Friends Research Institute, Inc.
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Cancer Institute (NCI)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- Region Skane
- University of Pennsylvania
- University of Pittsburgh
- Brown University
- Harvard University
- Duke University
- George Mason University
- Howard University
- Johns Hopkins University
- Lund University
- New York University
- Oregon Health and Science University
- Stanford University
- Sorlandet Hospital HF
- The Hospital of Vestfold
- The New York Academy of Medicine
- University of Houston
- +47 more
Organization Involved with Phase 3 Indications (61)
- Mayne Pharma
- Schering-Plough
- Titan Pharmaceuticals
- BioDelivery Sciences International
- Braeburn Pharmaceuticals
- Britannia Pharmaceuticals Ltd.
- The EMMES Corporation
- Research Foundation for Mental Hygiene, Inc.
- National Institute of Allergy and Infectious Diseases (NIAID)
- Cancer Research Network
- First People's Hospital of Foshan
- Hoosier Cancer Research Network
- National Cheng Kung University
- Northern State Medical University
- Osaka University
- Parkway Medical Center
- Rhode Island Hospital
- Russian Academy of Medical Sciences
- University of Hamburg
- University of Maryland
- University of Oslo
- University of South Florida
- West Virginia University
- University of Virginia
- Columbia University
- University of Cincinnati
- Pavlov First Saint Petersburg State Medical University
- Reckitt Benckiser Pharmaceutical
- Isfahan University
- Smolensk State Medical Academy
- +31 more
Organization Involved with Phase 2 Indications (62)
- Acura Pharmaceuticals Inc.
- MediciNova
- National Development and Research Institutes, Inc.
- Omeros Corporation
- Cassava Sciences
- National Institutes of Health (NIH)
- Hurd,Yasmin, Ph.D.
- Huazhong University of Science and Technology
- University of Arizona
- Central South University
- Baylor University
- Cornell University
- University of Washington
- Masaryk University
- Medical University Innsbruck
- Multidisciplinary Association for Psychedelic Studies
- St. Luke's-Roosevelt Hospital Center
- Sichuan University
- The Rogosin Institute
- Universidad Autonoma de Madrid
- University of Louisville
- University of Michigan
- University of New Mexico
- University of Regensburg
- University of Tehran
- University of Tennessee
- Western Michigan University
- University of Vermont
- University of Colorado, Denver
- University of Utah
- +32 more
Organization Involved with Phase 1 Indications (16)
- Vertex
- Grunenthal
- Tibotec
- Trevi Therapeutics
- MacDonald, Kai, M.D.
- University of London
- University of Nebraska
- Virginia Commonwealth University
- Pharmaceutical Research Associates, Inc. (PRA)
- Insys Therapeutics Inc
- NIFA Intramural Research Program
- University of Texas, San Antonio
- County of Stockholm
- Government of Sweden
- Syneos Health
- Altasciences Company Inc.
Organization Involved with Other Experimental Indications (6)